Top Markets
Coin of the day
PHAXIAM Therapeutics S.A. PHAXIAM Therapeutics S.A.

PHAXIAM Therapeutics S.A.

PHXM
Classement en actions #39465
PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating... PHAXIAM Therapeutics S.A. is a biopharmaceutical firm dedicated to creating therapies for drug-resistant bacterial infections, operating in both France and the U.S. The company's pipeline includes eryaspase, currently undergoing Phase 3 clinical trials for advanced pancreatic cancer and Phase 2 studies for treating triple-negative breast cancer and acute lymphoblastic leukemia after initial treatments. Additionally, PHAXIAM is advancing a range of phage therapies designed to combat hazardous, drug-resistant bacteria. These pathogens, such as Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa, are responsible for over two-thirds of all resistant infections acquired in hospital settings. Established in 2004, the company was previously known as ERYTECH Pharma S.A. before adopting the name PHAXIAM Therapeutics S.A. in June 2023. Its corporate headquarters are located in Lyon, France.
Prix de l'action
$0.11725176
Dernière synchronisation: 2025-07-14
Capitalisation boursière
$481.50K
Changement (1 jour)
-0.20%
Changement (1 an)
0.00%
Pays
FR
Échange PHAXIAM Therapeutics S.A. (PHXM)

Catégorie

Historique des divisions d’actions pour PHAXIAM Therapeutics S.A. (PHXM)
L’action PHAXIAM Therapeutics S.A. (symbole : PHXM) a subi un total de 2 divisions.
La division la plus récente a eu lieu le Jun 13, 2024.
Une action PHXM achetée avant le Sep 18, 2023 équivaudrait aujourd’hui à 0.10819672131148 actions PHXM.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
2024-06-13 66:61 x1.0819672131148 x0.10819672131148
2023-09-18 1:10 x0.1 x0.1
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE